Jingnan Wang Selected Research

3- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinone

2/2015	The combination of thioxodihydroquinazolinones and platinum drugs reverses platinum resistance in tumor cells by inducing mitochondrial apoptosis independent of Bax and Bak.
2/2015	A novel strategy for targeted killing of tumor cells: Induction of multipolar acentrosomal mitotic spindles with a quinazolinone derivative mdivi-1.
1/2015	Mitochondrial division inhibitor 1 (mdivi-1) enhances death receptor-mediated apoptosis in human ovarian cancer cells.
6/2014	Novel combination of mitochondrial division inhibitor 1 (mdivi-1) and platinum agents produces synergistic pro-apoptotic effect in drug resistant tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jingnan Wang Research Topics

Disease

28	Neoplasms (Cancer) 04/2022 - 09/2013
6	Inflammation (Inflammations) 12/2021 - 01/2018
5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 06/2014
5	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2014
4	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2015
3	Esophageal Squamous Cell Carcinoma 01/2018 - 10/2017
3	Spinal Cord Injuries (Spinal Cord Injury) 08/2017 - 09/2013
2	Bites and Stings (Sting) 04/2022 - 11/2019
2	Autoimmune Diseases (Autoimmune Disease) 02/2022 - 10/2018
2	Wounds and Injuries (Trauma) 04/2021 - 06/2015
2	Insulin Resistance 01/2021 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2017
2	Diabetes Mellitus 03/2020 - 01/2015
2	Hyperglycemia 07/2019 - 01/2015
2	Prostatic Neoplasms (Prostate Cancer) 06/2019 - 01/2019
2	Ovarian Neoplasms (Ovarian Cancer) 01/2015 - 06/2014
2	Hemolysis 12/2014 - 01/2014
1	Dehydration (Water Stress) 04/2022
1	Nephritis 02/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2022
1	Carcinogenesis 11/2021
1	Diabetic Foot 04/2021
1	Ulcer 04/2021
1	Lewis Lung Carcinoma 01/2021
1	Infections 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Thyroid Diseases (Thyroid Disease) 12/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Adenocarcinoma of Lung 01/2020
1	Tics (Tic) 12/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2019
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2019

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 02/2022 - 09/2013
4	Small Interfering RNA (siRNA)IBA 04/2022 - 09/2013
4	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 06/2014
4	3- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA 02/2015 - 06/2014
3	Long Noncoding RNAIBA 12/2021 - 01/2017
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 01/2020
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2019
2	InterferonsIBA 04/2022 - 11/2019
2	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 03/2020
2	Phosphotransferases (Kinase)IBA 04/2022 - 12/2021
2	MicroRNAs (MicroRNA)IBA 12/2021 - 02/2015
2	Leucine (L-Leucine)FDA Link 12/2021 - 03/2016
2	LigandsIBA 11/2021 - 01/2015
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2017
2	Biological ProductsIBA 01/2021 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 03/2017
2	RNA (Ribonucleic Acid)IBA 12/2019 - 01/2018
2	CytokinesIBA 11/2019 - 01/2018
2	177Lu-EB-PSMA-617IBA 06/2019 - 01/2019
2	177Lu-PSMA-617IBA 06/2019 - 01/2019
2	GlycogenIBA 01/2018 - 01/2014
2	Therapeutic UsesIBA 10/2017 - 03/2017
2	scutellarinIBA 03/2017 - 01/2015
2	Pharmaceutical PreparationsIBA 06/2015 - 06/2014
2	PlatinumIBA 02/2015 - 06/2014
1	PropaneIBA 04/2022
1	Alkenes (Olefins)IBA 04/2022
1	ethyleneIBA 04/2022
1	Oxygen (Dioxygen)IBA 04/2022
1	propylene (propene)IBA 04/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 04/2022
1	pristane (pristan)IBA 02/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2021
1	nitidineIBA 12/2021
1	protein kinase C nuIBA 11/2021
1	AntigensIBA 11/2021
1	68Ga-FAPIIBA 01/2021
1	Thymidine Monophosphate (TMP)IBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	EnzymesIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	ResistinIBA 01/2021
1	oil red OIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	tetramethylpyrazineIBA 01/2021
1	LipidsIBA 01/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	ParaffinIBA 01/2021
1	pembrolizumabIBA 12/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2020
1	Insulin (Novolin)FDA Link 03/2020
1	ApigeninIBA 07/2019
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2019
1	C-Reactive ProteinIBA 01/2019
1	Antimalarials (Antimalarial Agents)IBA 10/2018
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2018

Therapy/Procedure

10	Therapeutics 04/2022 - 09/2013
6	Immunotherapy 01/2022 - 12/2019
3	Drug Therapy (Chemotherapy) 01/2018 - 02/2015
2	Castration 06/2019 - 01/2019
2	Transplantation 08/2017 - 03/2016
1	Negative-Pressure Wound Therapy 04/2021
1	Precision Medicine 06/2019